| CAS编号 | 中文名 | 英文名 | 分子式 | 分子量 | 熔点 | 沸点 |
| 1402667-19-9 | | tert-butyl 4-(4-(2-aminoethyl)phenyl)piperidine-1-carboxylate | | | | |
| 1402671-55-9 | 2-甲基-5-(三氟甲基)吡啶-3-醇 | 2-Methyl-5-(trifluoromethyl)pyridin-3-ol | C7H6F3NO | 177.12 | | 286.8±35.0 °C(Predicted) |
| 1402672-14-3 | 2-溴-4,5,6,7-四氢吡唑并[1,5-a]吡嗪 | 2-Bromo-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine | C6H8BrN3 | 202.05 | | 327.2±42.0 °C(Predicted) |
| 1402672-24-5 | 2-(萘-2-基)哌啶盐酸盐 | 2-(Naphthalen-2-yl)piperidine hydrochloride | C15H18ClN | 247.76 | | |
| 1402672-55-2 | 5-氨基-6-溴吡啶-2-羧酸 | 5-Amino-6-bromo-pyridine-2-carboxylicacid | C6H5BrN2O2 | 217.02 | | |
| 1402672-70-1 | | tert-butyl 4-(3-(2-aminoethyl)phenyl)piperidine-1-carboxylate | | | | |
| 1402672-73-4 | 2-(吡咯烷-3-基)吡嗪二盐酸盐 | 2-(pyrrolidin-3-yl)pyrazine dihydrochloride | | | | |
| 1402672-77-8 | | 5-bromo-3,4-dihydro-2h-benzo[b][1,4]oxazine | C8H8BrNO | 214.06 | | |
| 1402672-79-0 | 2-Pyridinepropanenitrile,5-bromo-β-oxo- | 2-Pyridinepropanenitrile, 5-bromo-β-oxo- | C8H5BrN2O | 225.05 | | |
| 1402672-81-4 | 5-氨基-4-甲基吡啶-3-醇 | 5-Amino-4-methylpyridin-3-ol | C6H8N2O | 124.14 | | 430.8±40.0 °C(Predicted) |
| 1402673-66-8 | N-Boc-4-溴-2,6-二氟苄胺 | tert-Butyl (4-bromo-2,6-difluorobenzyl)carbamate | C12H14BrF2NO2 | 322.1500 | | |
| 1402687-79-9 | 2-[(2R)-1-tert-butoxycarbonyl-4,4-difluoro-pyrrolidin-2-yl]acetic acid | | C11H17NO4F2 | 265.2531 | | |
| 1402694-33-0 | | methyl 2-oxo-4-(4,4,4-trifluoro-3-oxobutyl)-1,2,3,4-tetrahydroquinoline-8-carboxylate | | | | |
| 14027-75-9 | 3-氟-5-硝基苯甲酸 | 3-fluoro-5-nitrobenzoic acid | C7H4FNO4 | 185.11 | | |
| 14027-78-2 | | hexanedioic acid dipentyl ester | C16H30O4 | 286.41 | | |
| 1402709-93-6 | CCT241736 | | C22H23Cl2N7 | 456.37 | | |
| 1402709-99-2 | | 1-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]piperazine hydrochloride | | | | |
| 1402714-41-3 | 4-[3-(2,5-二氯-4,6-二甲基-1-氧代-3-吡啶基)-1,2,4-噁二唑-5-基]-2-甲氧基-6-硝基苯酚 | 4-[3-(2,5-dichloro-4,6-dimethyl-1-oxido-3-pyridinyl)-1,2,4-o | | | | |
| 1402714-51-5 | (S)-2-(叔丁氧基)-2-((R)-4-(2,3-二氢吡喃并[4,3,2-de]喹啉-7-基)-2-甲基喹啉-3-基)基)乙酸甲酯 | (S)-methyl 2-(tert-butoxy)-2-((R)-4-(2,3-dihydropyrano[4,3,2-de]quinolin-7-yl)-2-methylquinolin-3-yl)acetate | C28H28N2O4 | 456.53 | | |
| 1402724-43-9 | 3-(Acridin-9-ylmethyl)thiazolidine-2,4-dione | | C17H12N2O2S | 308.36 | | |
| 1402727-29-0 | e式-pe859 | pe859 | C28H24N4O2 | 448.52 | | |
| 1402731-34-3 | 4-羟基-4-甲基-3-氧代戊酸乙酯 | Ethyl 4-hydroxy-4-methyl-3-oxopentanoate | C8H14O4 | 174.19 | | 242.9±15.0 °C(Predicted) |
| 1402742-11-3 | 2-(苄氧基)-1-(2-氟苯基)乙酮 | 2-(Benzyloxy)-1-(2-fluorophenyl)ethanone | C15H13FO2 | 244.2609 | | |
| 1402742-26-0 | | tert-butyl 3,5-difluoropicolinate | C10H11F2NO2 | 215.1967 | | |
| 14028-05-8 | | salicylic acid, 4-(3-morpholinopropionamido)-, pentyl ester, hydrochloride | | | | |
| 14028-08-1 | | salicylic acid, 4-(2-piperidinoacetamido)-, hexyl ester, hydrochloride | | | | |
| 14028-10-5 | | salicylic acid, 4-(3-(diethylamino)propionamido)-, hexyl ester, hydrochloride | | | | |
| 14028-12-7 | | salicylic acid, 4-(3-(isopropylamino)propionamido)-, hexyl ester, hydrochloride | | | | |
| 14028-14-9 | | salicylic acid, 4-(3-piperidinopropionamido)-, hexyl ester, hydrochloride | | | | |
| 14028-16-1 | | salicylic acid, 4-(3-morpholinopropionamido)-, hexyl ester, hydrochloride | | | | |
| 14028-18-3 | | salicylic acid, 4-(2-(diethylamino)acetamido)-, 2-diethylaminoethyl ester, dihy | | | | |
| 14028-20-7 | | salicylic acid, 4-(2-(isopropylamino)acetamido)-, 2-diethylaminoethyl ester, di | | | | |
| 14028-24-1 | | salicylic acid, 4-(2-morpholinoacetamido)-, 2-diethylaminoethyl ester, dihydroc | | | | |
| 14028-29-6 | | 3'-hydroxy-2-piperidino-4'-piperidinocarbonyl-acetanilid hydrochloride | | | | |
| 14028-32-1 | | 3'-hydroxy-2-morpholino-4'-morpholinocarbonyl-acetanilid hydrochloride | | | | |
| 14028-36-5 | | 2-cyclohexylamino-4'-cyclohexylcarbamoyl-3'-hydroxy-acetanilid hydrochlorid | | | | |
| 14028-44-5 | 氯氧平 | 2-Chloro-11(1-Piperazinyl)dibenz [b,f] [1,4]oxazepine | C17H16ClN3O | 313.79 | | |
| 14028-62-7 | | D-Glyceric acid calcium salt dihydrate | | | 141℃ | |
| 14028-63-8 | | l-glyceric acid hemicalcium salt monohydrate | C3H5O4.1/2Ca | 145.15 | 134℃ | |
| 14028-68-3 | 丁苯那嗪中间体;1-乙氧羰基-6,7-二甲氧基-1,2,3,4-四氢异喹啉 | ethyl 2-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-1-yl)acetate | C15H21NO4 | 279.33 | | 391.202°C at 760 mmHg |
| 14028-72-9 | | n-(2-(4-benzyloxy-3-methoxy-phenyl)-ethyl)-2-(4-methoxy-phenyl)-acetamide | | | | |
| 1402805-31-5 | (S)-3-氨基庚-1-醇盐酸盐 | (S)-3-aminoheptan-1-ol hydrochloride | C7H18ClNO | 167.68 | | |
| 1402812-89-8 | 3-乙基异噁唑-4-甲酸甲酯 | methyl 3-ethylisoxazole-4-carboxylate | | | | |
| 1402821-24-2 | | ca2+ channel agonist 1 | C19H26N6O | 354.45 | | |
| 1402821-41-3 | | gv-58 | C18H26N6OS | 374.5 | | |
| 1402830-75-4 | | ceranib-2 | C25H19NO3 | 381.42 | | |
| 1402836-58-1 | 5-(2-环己基-2-羟基乙基)-5h-咪唑并[5,1-a]异吲哚 | 5-(2-cyclohexyl-2-hydroxyethyl)-5h-imidazo[5,1-a]isoindole | C18H22N2O | 282.38 | | |
| 1402836-76-3 | 1-Cyclohexyl-2-(6-fluoro-5H-imidazo[5,1-a]isoindol-5-yl)ethanol | | C18H21FN2O | 300.4 | | |
| 1402836-86-5 | 4-(2-(6-Fluoro-5H-imidazo[5,1-α]isoindol-5-yl)-1-hydroxyethyl)cyclohexanol | | C18H21FN2O2 | 316.4 | | |
| 1402837-76-6 | | ido-in-6 | C18H21FN2O2 | 316.37 | | |
m.cnreagent.com